Noom Med, MD-Led Platform

Noom Med is the prescription weight loss arm of Noom, the New York-based digital health company known for its psychology-based approach to behavior change in weight management. Where most GLP-1 telehealth platforms treat medication access as the core product and coaching as an optional add-on, Noom inverts this logic: the behavior-change platform came first, and medication was layered in to amplify a program that had already helped millions of people. The GLP-1 Companion — Noom''s digital support layer for medication users — includes daily psychology-based lessons, personalized nutrition guidance, side-effect management tools, habit coaching, and community support from others on GLP-1 therapy. Real-world Noom data shows that members who engage more deeply with the GLP-1 Companion experience greater weight loss and stay on medication longer, which the company presents as evidence that behavioral infrastructure meaningfully augments pharmacological treatment. Noom Med offers two prescription tracks. The standard full-dose program begins at $149 for the first month and runs $299/month thereafter, providing compounded semaglutide alongside full Noom platform access. The microdose GLP-1Rx program — starting at $79 and $199/month thereafter — offers lower starting doses to reduce common early side effects like nausea and vomiting, a protocol that appeals to patients who have been hesitant to try full-dose injections. Patients with insurance who want brand-name GLP-1s can access Noom''s telehealth prescribing service for prior authorization support. Licensed telehealth providers are available via unlimited messaging, with one-on-one visits available for clinical questions or dosing decisions. Noom Med operates in all states where its telehealth provider network is credentialed and does not rely on a single national provider network — it manages a team of contracted clinicians. Noom Med positions itself at the intersection of digital therapeutics and pharmaceutical weight loss, arguing that neither medication nor behavioral coaching alone produces durable results. For patients who want structured psychological support woven into their GLP-1 journey rather than a bare-bones prescription service, Noom Med offers infrastructure that most competitors do not have. behavior-change platform came first, and medication was layered in to amplify a program that had already helped millions of people. The GLP-1 Companion — Noom''s digital support layer for medication users — includes daily psychology-based lessons, personalized nutrition guidance, side-effect management tools, habit coaching, and community support from others on GLP-1 therapy. Real-world Noom data shows that members who engage more deeply with the GLP-1 Companion experience greater weight loss and stay on medication longer, which the company presents as evidence that behavioral infrastructure meaningfully augments pharmacological treatment. Noom Med offers two prescription tracks. The standard full-dose program begins at $149 for the first month and runs $299/month thereafter, providing compounded semaglutide alongside full Noom platform access. The microdose GLP-1Rx program — starting at $79 and $199/month thereafter — offers lower starting doses to reduce common early side effects like nausea and vomiting, a protocol that appeals to patients who have been hesitant to try full-dose injections. Patients with insurance who want brand-name GLP-1s can access Noom''s telehealth prescribing service for prior authorization support. Licensed telehealth providers are available via unlimited messaging, with one-on-one visits available for clinical questions or dosing decisions. Noom Med operates in all states where its telehealth provider network is credentialed and does not rely on a single national provider network — it manages a team of contracted clinicians. Noom Med positions itself at the intersection of digital therapeutics and pharmaceutical weight loss, arguing that neither medication nor behavioral coaching alone produces durable results. For patients who want structured psychological support woven into their GLP-1 journey rather than a bare-bones prescription service, Noom Med offers infrastructure that most competitors do not have.